Skip to content

Comparison between levobupivacaine and bupivacaine on vasodilatory effect in spinal anaesthesia in below umbilicus surgery

EFFECT OF 0.5% LEVOBUPIVACAINE AND BUPIVACAINE HEAVY ON PERFUSION INDEX IN INFRAUMBILICAL SURGERIES: A RANDOMIZED, DOUBLE-BLIND STUDY - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061800
Enrollment
140
Registered
2024-01-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Levobupivacaine: 0.5% levobupivacaine for spinal block 3ml of drug will be administer Duration of intervention 120min Control Intervention1: Bupivacaine: 0.5% bupivacaine for spinal b

Sponsors

DEPARTMENT OF ANESTHESIOLOGY AIIMS DEOGHAR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patient with ASA1, 2 will be included and BMI of 18.5 to 29.99kg/m2 bsa

Exclusion criteria

Exclusion criteria: Contraindication to spinal anaesthesia Known allergies to local anaesthesia Peripheral vascular diseases Kown or suspected autonomic neuropathy Pregnancy

Design outcomes

Primary

MeasureTime frame
Compare the vasodilatory effect of 0.5% levobupivacaine and 0.5% bupavacaine heavy after spinal anaesthesiaTimepoint: Blood pressure and perfusion index will be check at 2 min, 3min,5min,10min,25min,30min,35min,40min,45min,50min,55min,60min,70min,80min,90min,100min, 110min,120min,after spinal anaesthesia

Secondary

MeasureTime frame
Changes in blood pressure and heart rate evaluation after spinal anaesthesia Prediction of perfusion index for spinal anaesthesia induce hypotensionTimepoint: Blood pressure, heart rate, will be noted at 1,2,3,5,10,15,20,25,30,35,40,45,50,55,60,70,80,90,100,110,120 min

Countries

India

Contacts

Public ContactSUCHITA VIJAY MESHRAM

AIIMS DEOGHAR

drsanjayaiims2012@gmail.com7063956225

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026